Alto Neuroscience ANRO Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's stock issuance proceeds?
- Alto Neuroscience (ANRO) reported stock issuance proceeds of $6K in Q1 2026.
- How has Alto Neuroscience's stock issuance proceeds changed year-over-year?
- Alto Neuroscience's stock issuance proceeds decreased by 97.0% year-over-year, from $198K to $6K.
- What is the long-term trend for Alto Neuroscience's stock issuance proceeds?
- Over 2 years (2023 to 2025), Alto Neuroscience's stock issuance proceeds has grown at a 97.1% compound annual growth rate (CAGR), from $181K to $703K.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.